Literature DB >> 28189604

Transcriptional regulation of Hhex in hematopoiesis and hematopoietic stem cell ontogeny.

Rosa Portero Migueles1, Louise Shaw2, Neil P Rodrigues3, Gillian May4, Korinna Henseleit1, Kathryn G V Anderson5, Hakan Goker6, C Michael Jones6, Marella F T R de Bruijn2, Joshua M Brickman7, Tariq Enver8.   

Abstract

Hematopoietic stem cells (HSCs) emerge during development via an endothelial-to-hematopoietic transition from hemogenic endothelium of the dorsal aorta (DA). Using in situ hybridization and analysis of a knock-in RedStar reporter, we show that the transcriptional regulator Hhex is expressed in endothelium of the dorsal aorta (DA) and in clusters of putative HSCs as they are specified during murine development. We exploited this observation, using the Hhex locus to define cis regulatory elements, enhancers and interacting transcription factors that are both necessary and sufficient to support gene expression in the emerging HSC. We identify an evolutionarily conserved non-coding region (ECR) in the Hhex locus with the capacity to bind the hematopoietic-affiliated transcriptional regulators Gata2, SCL, Fli1, Pu.1 and Ets1/2. This region is sufficient to drive the expression of a transgenic GFP reporter in the DA endothelium and intra-aortic hematopoietic clusters. GFP-positive AGM cells co-expressed HSC-associated markers c-Kit, CD34, VE-Cadherin, and CD45, and were capable of multipotential differentiation and long term engraftment when transplanted into myelo-ablated recipients. The Hhex ECR was also sufficient to drive expression at additional blood sites including the yolk sac blood islands, fetal liver, vitelline and umbilical arteries and the adult bone marrow, suggesting a common mechanism for Hhex regulation throughout ontogenesis of the blood system. To explore the physiological requirement for the Hhex ECR region during hematoendothelial development, we deleted the ECR element from the endogenous locus in the context of a targeted Hhex-RedStar reporter allele. Results indicate a specific requirement for the ECR in blood-associated Hhex expression during development and further demonstrate a requirement for this region in the adult HSC compartment. Taken together, our results identified the ECR region as an enhancer both necessary and sufficient for gene expression in HSC development and homeostasis. The Hhex ECR thus appears to be a core node for the convergence of the transcription factor network that governs the emergence of HSCs.
Copyright © 2017. Published by Elsevier Inc.

Entities:  

Keywords:  Blood; Development and differentiation; Enhancer; Transcription

Mesh:

Substances:

Year:  2017        PMID: 28189604     DOI: 10.1016/j.ydbio.2016.12.021

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.582


  6 in total

1.  Hhex induces promyelocyte self-renewal and cooperates with growth factor independence to cause myeloid leukemia in mice.

Authors:  Jacob T Jackson; Ashley P Ng; Benjamin J Shields; Sue Haupt; Ygal Haupt; Matthew P McCormack
Journal:  Blood Adv       Date:  2018-02-27

Review 2.  Enhancer DNA methylation in acute myeloid leukemia and myelodysplastic syndromes.

Authors:  Leonidas Benetatos; George Vartholomatos
Journal:  Cell Mol Life Sci       Date:  2018-02-26       Impact factor: 9.261

3.  Single-cell transcriptomics reveal the dynamic of haematopoietic stem cell production in the aorta.

Authors:  Chloé S Baron; Lennart Kester; Anna Klaus; Jean-Charles Boisset; Roshana Thambyrajah; Laurent Yvernogeau; Valérie Kouskoff; Georges Lacaud; Alexander van Oudenaarden; Catherine Robin
Journal:  Nat Commun       Date:  2018-06-28       Impact factor: 14.919

4.  DNA methylation profiling implicates exposure to PCBs in the pathogenesis of B-cell chronic lymphocytic leukemia.

Authors:  Panagiotis Georgiadis; Marios Gavriil; Panu Rantakokko; Efthymios Ladoukakis; Maria Botsivali; Rachel S Kelly; Ingvar A Bergdahl; Hannu Kiviranta; Roel C H Vermeulen; Florentin Spaeth; Dennie G A J Hebbels; Jos C S Kleinjans; Theo M C M de Kok; Domenico Palli; Paolo Vineis; Soterios A Kyrtopoulos
Journal:  Environ Int       Date:  2019-02-15       Impact factor: 9.621

5.  NKL Homeobox Genes NKX2-3 and NKX2-4 Deregulate Megakaryocytic-Erythroid Cell Differentiation in AML.

Authors:  Stefan Nagel; Claudia Pommerenke; Corinna Meyer; Roderick A F MacLeod
Journal:  Int J Mol Sci       Date:  2021-10-22       Impact factor: 5.923

6.  NKL homeobox gene MSX1 acts like a tumor suppressor in NK-cell leukemia.

Authors:  Stefan Nagel; Claudia Pommerenke; Corinna Meyer; Maren Kaufmann; Roderick A F MacLeod; Hans G Drexler
Journal:  Oncotarget       Date:  2017-06-21
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.